SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Blue-and-white Black Hat: How Israel came to dominate cyber's biggest conference

Base44 founder Maor Shlomo launches cancer research fund after losing his mother to the disease

Israeli chip company Xsight Labs raises $300 million at $2.8 billion valuation

“We are prepared to be very aggressive”: Check Point signals appetite for a major cyber acquisition

Buzz

Most popular

Daily

Weekly

1

ServiceNow continues layoffs as it restructures around AI

2

“We want to replace Datadog”: groundcover raises $100 million at $500 million valuation as AI reshapes observability

3

AI security startup Onyx raises $113 million Series B at $640 million valuation

4

Cyber unicorn Cyera acquires Oasis Security in $1 billion deal

5

Jared Kushner’s Affinity Partners sells $343 million Phoenix stake after fivefold return

Nasdaq

20 stories about Nasdaq

נאסד"ק וול סטריט

RedHill’s Clinical Trial Results Undermine Its Underwritten Offering

12.08.18|Dror Reich

The gastro treatment company announced a successful Crohn's disease treatment trial two weeks ago. While investors initially seemed hyped, successful trials from competitors brought RedHill’s stock down since

פאנל סולארי אנרגיה מתחדשת

SolarEdge Extends Patents Lawsuit Against Huawei

01.08.18|Amarelle Wenkert

The solar energy company has a pending lawsuit in Germany against the Chinese telecommunications company and a German distributor

Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial

30.07.18|Lilach Baumer

The Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints

נאסדק נאסד"ק ניו יורק בורסה בועה

Surveillance Company Ability Looking to Raise Up to $50 Million in Shelf Offering

Earlier this month, the Tel Aviv-based company announced it has received a delisting determination from Nasdaq

In Pivot, AudioCodes to Pay Out Dividends

25.07.18|Dror Reich

Revenue grew 12.3 percent to $43.5 million compared to the second quarter of last year

נאסדק נאסד"ק ניו יורק בורסה בועה

Wix.com Reports Higher Revenue and Improved Yearly Forecast

25.07.18|Asaf Shalev

The provider of website building tools also said it turned a profit in the second quarter excluding one-time items

מנכ"ל מדיגוס כריס רולנד

Medical Device Company Medigus Raises $10 Million in Public Offering

Medigus develops minimally invasive endosurgical tools and direct visualization technology

נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer

The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market

נאסד"ק וול סטריט

Nasdaq Sends Notice of Delisting to Interception Company Ability

Last week, Tel Aviv-based Ability announced the SEC is considering disciplinary action against it in connection to a 2015 merger, and to business information filed by the company

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum

Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections

נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials

נאסדק נאסד"ק ניו יורק בורסה בועה

SEC Considering Disciplinary Action Against Interception Company Ability

09.07.18|Dror Reich

Tel Aviv-based Ability has been under probe since February 2017 in regards to a 2015 merger, and to business information filed by the company

נאסד"ק וול סטריט

Cybersecurity Company Safe-T Group Submits Preliminary Prospectus for Nasdaq IPO

08.07.18|Lilach Baumer

The company is currently listed on the Tel Aviv Stock Exchange and on the OTCQB venture market

נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich

The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each

פרופסור קרין נהון נשיאת איגוד האינטרנט

CTech's Monday Roundup of Israeli Tech News

Israeli civil liberties groups warn against potential for abuse in cybersecurity bill. After hitting new low, surveillance company Ability jumps on Nasdaq

ברק עילם מנכל נייס

Nice Extends Mattersight Tender Offer for the Fourth Time

25.06.18|Dror Reich

The Israeli software company announced the acquisition agreement in April, but has been held back by the American regulator again and again

נאסד"ק וול סטריט

After Hitting New Low, Interception Company Ability Jumps on Nasdaq

25.06.18|Dror Reich

The company closed at $2.16 on Wednesday and at $4.99 on Friday, and is currently almost 10% up in pre-trading

אבישי אברהמי מ מייסדי ו מנכל חברת וויקס

Wix Looking to Raise $385 Million in Private Offering

24.06.18|Lilach Baumer

In May, Wix published its first-quarter report for 2018, reporting revenue of $137.8 million, up 49% from a year earlier

נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich

Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study

אייל ולדמן מלאנוקס

Mellanox and Starboard Nearing Agreement Over Board Seats, Report Says

18.06.18|Dror Reich

The two companies had been brawling over the makeup of Mellanox’s board since Starboard became the chipmaker’s largest shareholder in November

Previous Articles More Articles